The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells

FASEB Journal

Volumn 22, Issue 8, 2008, Pages 2690-2701

  Kirschner, Karin M ^a   Hagen, Patricia ^a   Hussels, Christiane S ^a   Ballmaier, Matthias ^b   Scholz, Holger ^a   Dame, Christof ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Colony forming unit erythroid; Development; Erythropoiesis; Gene expression; Oncogene

Indexed keywords

ERYTHROPOIETIN RECEPTOR; ISOPROTEIN; WT1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COLONY FORMING UNIT; CONTROLLED STUDY; EMBRYO; ERYTHROLEUKEMIA; GEL MOBILITY SHIFT ASSAY; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; MUTATIONAL ANALYSIS; NEPHROBLASTOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; WILD TYPE;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; DNA; DNA PRIMERS; EMBRYONIC STEM CELLS; ERYTHROPOIESIS; ERYTHROPOIETIN, RECOMBINANT; GENES, REPORTER; GENES, WILMS TUMOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HETEROZYGOTE; HUMANS; MICE; MICE, KNOCKOUT; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, ERYTHROPOIETIN; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSFECTION; WT1 PROTEINS;

MURINAE; MUS;

EID: 48749094720     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-097576     Document Type: Article

References (57)

1. Hastie, N. D. (1994) The genetics of Wilms' tumor - a case of disrupted development. Annu. Rev. Genet. 28, 523-558
2. Hohenstein, P., and Hastie, N. D. (2006) The many facets of the Wilms' tumour gene, WT1. Hum. Mol. Genet. 15(Spec. 2), R196-R201
3. Baird, P. N., and Simmons, P. J. (1997) Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis. Exp. Hematol. 25, 312-320
4. Hosen, N., Sonoda, Y., Oji, Y., Kimura, T., Minamiguchi, H., Tamaki, H., Kawakami, M., Asada, M., Kanato, K., Motomura, M., Murakami, M., Fujioka, T., Masuda, T., Kim, E. H., Tsuboi, A., Oka, Y., Soma, T., Ogawa, H., and Sugiyama, H. (2002) Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells. Br. J. Haematol. 116, 409-420
5. Fraizer, G. C., Patmasiriwat, P., Zhang, X., and Saunders, G. F. (1995) Expression of the tumor suppressor gene WT1 in both human and mouse bone marrow. Blood 86, 4704-4706
6. Maurer, U., Brieger, J., Weidmann, E., Mitrou, P. S., Hoelzer, D., and Bergmann, L. (1997) The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro. Exp. Hematol. 25, 945-950
7. Alberta, J. A., Springett, G. M., Rayburn, H., Natoli, T. A., Loring, J., Kreidberg, J. A., and Housman, D. (2003) Role of the WT1 tumor suppressor in murine hematopoiesis. Blood 101, 2570-2574
8. Ellisen, L. W., Carlesso, N., Cheng, T., Scadden, D. T., and Haber, D. A. (2001) The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells. EMBO J. 20, 1897-1909
9. Loeb, D. M., Summers, J. L., Burwell, E. A., Korz, D., Friedman, A. D., and Sukumar, S. (2003) An isoform of the Wilms' tumor suppressor gene potentiates granulocytic differentiation. Leukemia 17, 965-971
10. King-Underwood, L., Little, S., Baker, M., Clutterbuck, R., Delassus, S., Enver, T., Lebozer, C., Min, T., Moore, A., Schedl, A., and Pritchard-Jones, K. (2005) Wt1 is not essential for hematopoiesis in the mouse. Leuk. Res. 29, 803-812
11. Haber, D. A., Sohn, R. L., Buckler, A. J., Pelletier, J., Call, K. M., and Housman, D. E. (1991) Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc. Natl. Acad. Sci. U. S. A. 88, 9618-9622
12. Englert, C., Vidal, M., Maheswaran, S., Ge, Y., Ezzell, R. M., Isselbacher, K. J., and Haber, D. A. (1995) Truncated WT1 mutants alter the subnuclear localization of the wild-type protein. Proc. Natl. Acad. Sci. U. S. A. 92, 11960-11964
13. Larsson, S. H., Charlieu, J. P., Miyagawa, K., Engelkamp, D., Rassoulzadegan, M., Ross, A., Cuzin, F., van Heyningen, V., and Hastie, N. D. (1995) Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81, 391-401
14. Lee, S. B., and Haber, D. A. (2001) Wilms tumor and the WT1 gene. Exp. Cell. Res. 264, 74-99
15. Pritchard-Jones, K., Fleming, S., Davidson, D., Bickmore, W., Porteous, D., Gosden, C., Bard, J., Buckler, A., Pelletier, J., Housman, D., Van Heyningen, V., Hastie, N. (1990) The candidate Wilms' tumour gene is involved in genitourinary development. Nature 346, 194-197
16. Kreidberg, J. A., Sariola, H., Loring, J. M., Maeda, M., Pelletier, J., Housman, D., and Jaenisch, R. (1993) WT-1 is required for early kidney development. Cell 74, 679-691
17. Herzer, U., Crocoll, A., Barton, D., Howells, N., and Englert, C. (1999) The Wilms tumor suppressor gene wt1 is required for development of the spleen. Curr. Biol. 9, 837-840
18. Wagner, K. D., Wagner, N., Vidal, V. P., Schley, G., Wilhelm, D., Schedl, A., Englert, C., and Scholz, H. (2002) The Wilms' tumor gene Wt1 is required for normal development of the retina. EMBO J. 21, 1398-1405
19. Wagner, N., Wagner, K. D., Hammes, A., Kirschner, K. M., Vidal, V. P., Schedl, A., and Scholz, H. (2005) A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system. Development 132, 1327-1336
20. Maheswaran, S., Park, S., Bernard, A., Morris, J. F., Rauscher, F. J., 3rd, Hill, D. E., and Haber, D. A. (1993) Physical and functional interaction between WT1 and p53 proteins. Proc. Natl. Acad. Sci. U. S. A. 90, 5100-5104
21. Wang, W., Lee, S. B., Palmer, R., Ellisen, L. W., and Haber, D. A. (2001) A functional interaction with CBP contributes to transcriptional activation by the Wilms tumor suppressor WT1. J. Biol. Chem. 276, 16810-16816
22. Dame, C., Kirschner, K. M., Bartz, K. V., Wallach, T., Hussels, C. S., and Scholz, H. (2006) Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin gene. Blood 107, 4282-4290
23. Wu, H., Liu, X., Jaenisch, R., and Lodish, H. F. (1995) Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83, 59-67
24. Lin, C. S., Lim, S. K., D'Agati, V., and Costantini, F. (1996) Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev. 10, 154-164
25. Komatsu, N., and Fujita, H. (1993) Induced megakaryocytic maturation of the human leukemia cell line UT-7 results in down-modulation of erythropoietin receptor gene expression. Cancer Res. 53, 1156-1161
26. Migliaccio, A. R., Jiang, Y., Migliaccio, G., Nicolis, S., Crotta, S., Ronchi, A., Ottolenghi, S., and Adamson, J. W. (1993) Transcriptional and posttranscriptional regulation of the expression of the erythropoietin receptor gene in human erythropoietin-responsive cell lines. Blood 82, 3760-3769
27. Migliaccio, A. R., Migliaccio, G., D'Andrea, A., Baiocchi, M., Crotta, S., Nicolis, S., Ottolenghi, S., and Adamson, J. W. (1991) Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface. Proc. Natl. Acad. Sci. U. S. A. 88, 11086-11090
28. Maouche, L., Cartron, J. P., and Chretien, S. (1994) Different domains regulate the human erythropoietin receptor gene transcription. Nucleic Acids Res. 22, 338-346
29. Zon, L. I., Youssoufian, H., Mather, C., Lodish, H. F., and Orkin, S. H. (1991) Activation of the erythropoietin receptor promoter by transcription factor GATA-1. Proc. Natl. Acad. Sci. U. S. A. 88, 10638-10641
30. Chiba, T., Ikawa, Y., and Todokoro, K. (1991) GATA-1 transactivates erythropoietin receptor gene, and erythropoietin receptor-mediated signals enhance GATA-1 gene expression. Nucleic Acids Res. 19, 3843-3848
31. Chin, K., Oda, N., Shen, K., and Noguchi, C. T. (1995) Regulation of transcription of the human erythropoietin receptor gene by proteins binding to GATA-1 and Sp1 motifs. Nucleic Acids Res. 23, 3041-3049
32. Dame, C., Sola, M. C., Fandrey, J., Rimsza, L. M., Freitag, P., Knopfle, G., Christensen, R. D., and Bungert, J. (2002) Developmental changes in the expression of transcription factors GATA-1, -2 and -3 during the onset of human medullary haematopoiesis. Br. J. Haematol. 119, 510-515
33. Orkin, S. H., Harosi, F. I., and Leder, P. (1975) Differentiation in erythroleukemic cells and their somatic hybrids. Proc. Natl. Acad. Sci. U. S. A. 72, 98-102
34. Haber, D. A., Park, S., Maheswaran, S., Englert, C., Re, G. G., Hazen-Martin, D. J., Sens, D. A., and Garvin, A. J. (1993) WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant. Science 262, 2057-2059
35. Dame, C., Fahnenstich, H., Freitag, P., Hofmann, D., Abdul-Nour, T., Bartmann, P., and Fandrey, J. (1998) Erythropoietin mRNA expression in human fetal and neonatal tissue. Blood 92, 3218-3225
36. Wagner, K. D., Wagner, N., Wellmann, S., Schley, G., Bondke, A., Theres, H., and Scholz, H. (2003) Oxygen-regulated expression of the Wilms' tumor suppressor Wt1 involves hypoxia-inducible factor-1 (HIF-1). FASEB J. 17, 1364-1366
37. Elliott, S., Busse, L., Bass, M. B., Lu, H., Sarosi, I., Sinclair, A. M., Spahr, C., Um, M., Van, G., and Begley, C. G. (2006) Anti-Epo receptor antibodies do not predict Epo receptor expression. Blood 107, 1892-1895
38. Brown, W. M., Maxwell, P., Graham, A. N., Yakkundi, A., Dunlop, E. A., Shi, Z., Johnston, P. G., and Lappin, T. R. (2007) Erythropoietin receptor expression in non-small cell lung carcinoma: a question of antibody specificity. Stem Cells 25, 718-722
39. Kirkeby, A., van Beek, J., Nielsen, J., Leist, M., and Helboe, L. (2007) Functional and immunochemical characterisation of different antibodies against the erythropoietin receptor. J. Neurosci. Methods 164, 50-58
40. Dame, C. (2003) Molecular biology of the erythropoietin receptor in hematopoietic and non-hematopoietic tissues. In Erythropoietin and Erythropoiesis (Molineux, G., Foote, M., and Elliott, S. G., eds) pp. 35-64, Birkhäuser, Basel, Switzerland
41. Minguet, S., Cortegano, I., Gonzalo, P., Martinez-Marin, J. A., de Andres, B., Salas, C., Melero, D., Gaspar, M. L., and Marcos, M. A. (2003) A population of c-Kit(low)(CD45/TER119)- hepatic cell progenitors of 11-day postcoitus mouse embryo liver reconstitutes cell-depleted liver organoids. J. Clin. Invest. 112, 1152-1163
42. Dan, Y. Y., Riehle, K. J., Lazaro, C., Teoh, N., Haque, J., Campbell, J. S., and Fausto, N. (2006) Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages. Proc. Natl. Acad. Sci. U. S. A. 103, 9912-9917
43. Goldberg, M. A., Glass, G. A., Cunningham, J. M., and Bunn, H. F. (1987) The regulated expression of erythropoietin by two human hepatoma cell lines. Proc. Natl. Acad. Sci. U. S. A. 84, 7972-7976
44. Wagner, K. D., Wagner, N., Sukhatme, V. P., and Scholz, H. (2001) Activation of vitamin D receptor by the Wilms' tumor gene product mediates apoptosis of renal cells. J. Am. Soc. Nephrol. 12, 1188-1196
45. Kieran, M. W., Perkins, A. C., Orkin, S. H., and Zon, L. I. (1996) Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor. Proc. Natl. Acad. Sci. U. S. A. 93, 9126-9131
46. Broudy, V. C., Lin, N., Brice, M., Nakamoto, B., and Papayannopoulou, T. (1991) Erythropoietin receptor characteristics on primary human erythroid cells. Blood 77, 2583-2590
47. Sawyer, S. T., Krantz, S. B., and Goldwasser, E. (1987) Binding and receptor-mediated endocytosis of erythropoietin in Friend virus-infected erythroid cells. J. Biol. Chem. 262, 5554-5562
48. Philo, J. S., Aoki, K. H., Arakawa, T., Narhi, L. O., and Wen, J. (1996) Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction. Biochemistry 35, 1681-1691
49. Svedberg, H., Richter, J., and Gullberg, U. (2001) Forced expression of the Wilms tumor 1 (WT1) gene inhibits proliferation of human hematopoietic CD34(+) progenitor cells. Leukemia 15, 1914-1922
50. Chen, D., and Zhang, G. (2001) Enforced expression of the GATA-3 transcription factor affects cell fate decisions in hematopoiesis. Exp. Hematol. 29, 971-980
51. Pandolfi, P. P., Roth, M. E., Karis, A., Leonard, M. W., Dzierzak, E., Grosveld, F. G., Engel, J. D., and Lindenbaum, M. H. (1995) Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat. Genet. 11, 40-44
52. Komatsu, N., Kirito, K., Kashii, Y., Furukawa, Y., Kikuchi, J., Suwabe, N., Yamamoto, M., and Miura, Y. (1997) Cell-cycle-dependent regulation of erythropoietin receptor gene. Blood 89, 1182-1188
53. Leonard, M., Brice, M., Engel, J. D., and Papayannopoulou, T. (1993) Dynamics of GATA transcription factor expression during erythroid differentiation. Blood 82, 1071-1079
54. Wu, Y., Fraizer, G. C., and Saunders, G. F. (1995) GATA-1 transactivates the WT1 hematopoietic specific enhancer. J. Biol. Chem. 270, 5944-5949
55. Zhang, X., Xing, G., Fraizer, G. C., and Saunders, G. F. (1997) Transactivation of an intronic hematopoietic-specific enhancer of the human Wilms' tumor 1 gene by GATA-1 and c-Myb. J. Biol. Chem. 272, 29272-29280
56. Noguchi, C. T., Asavaritikrai, P., Teng, R., and Jia, Y. (2007) Role of erythropoietin in the brain. Crit. Rev. Oncol. Hematol. 64, 159-171
57. Fandrey, J. (2006) A cordial affair-erythropoietin and cardioprotection. Cardiovasc. Res. 72, 1-2